Tms
4891.TTSE GROWTHPharmaceutical
Filed as TMS Co.,Ltd. (2023-01–2023-01), TMS Co., Ltd. (2023-05–2026-08)
Financials · Standalone
| Fiscal year ended | 2025-12 | 2025-02 | 2024-02 | 2023-02 | 2022-02 | 2021-02 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | ¥1.9bn | — |
| Operating income | −¥697m | −¥908m | −¥943m | −¥520m | ¥1.1bn | — |
| Ordinary income | −¥712m | −¥633m | −¥943m | −¥861m | ¥1.1bn | −¥720m |
| Total assets | ¥2.9bn | ¥3.0bn | ¥3.6bn | ¥3.8bn | ¥2.7bn | ¥1.2bn |
| Net assets / equity | ¥2.8bn | ¥2.8bn | ¥3.5bn | ¥3.7bn | ¥2.5bn | ¥1.1bn |
| Operating cash flow | −¥780m | −¥494m | −¥823m | −¥688m | ¥1.3bn | −¥738m |
| EPS (basic) | ¥-16.08 | ¥-16.38 | ¥-26.02 | ¥-25.28 | ¥53.36 | ¥-171.47 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 3
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 60 figures · EDINET |
| 2025-03-01 → 2025-08-31 | Half-year | 61 figures · EDINET |
| 2024-03-01 → 2024-08-31 | Half-year | 61 figures · EDINET |